Modeling projects anthracycline recipients may lose a median 9.4 life-years to age acceleration, a finding with survivorship care implications.
|Videos|September 12, 2016
Melanoma Survivors Encourage Others to Protect Their Skin
Author(s)Melanoma Foundation of New England
Advertisement
Melanoma is the second most common form of cancer for young people ages 15-29. It is a disease that affects a younger population. But the good news is: it’s preventable. By taking proper precautions and checking yourself monthly, you can protect yourself against melanoma.
Hear young survivors share their stories of survival.
Advertisement
Related to this article
Oncology NPs and PAs are key to closing workforce gaps. Here’s how generalist, specialist, and hybrid APP models improve access and outcomes.
Perioperative durvalumab with enfortumab vedotin given only before cystectomy cut the risk of an EFS event by 49% in the phase 3 VOLGA trial.
With 10 years of oncology nursing experience, Lee Grabb highlights how nurse navigation, human connection, and compassion transform holistic cancer care.
Lisa Carter-Bawa, PhD, MPH, APRN, explains how blame keeps patients from lung cancer care and how nurses can counter that stigma in the community.
A study of 6 palliative care programs tied trust, proximity, and real-time communication with oncology teams to higher hospice use.
At the 10th Annual School of Nursing Oncology, faculty said nurses need fast, disease-specific updates to educate patients and manage novel therapies.
Experts detail evidence for exercise, acupuncture, and mind-body care during radiation, and the knowledge and referral gaps that limit uptake.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Durvalumab-Enfortumab Vedotin for Cisplatin-Ineligible MIBC
2
SONO 2026: Nurses Remain the Front Line as Cancer Therapies Evolve
3
How Oncology Nurses Can Dismantle Lung Cancer Stigma
4
Advanced Practice Providers: Essential Partners in Modern Oncology Care
5